Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, start-up companies, business ventures and equity investments.
Below is a small sampling.
Impact stories
Platform therapy PMM2-CDG
Discovery leads to life-changing treatment for young girl with ultra-rare disease
Stem cell therapy
For Perianal Fistulas in Patients with Crohn’s Disease
Pursuit of cures, backed by collaboration
Taking research discoveries from bench to bedside
Oncolytic virus therapies
Sodium-iodide symporter reporter gene imaging system
Phage therapy treatment
Using viruses to target and kill specific bacteria
Evolving vaccine efforts
Single-cycle adenovirus vaccine platform
Cancer screening revolution
FDA-approved noninvasive colorectal screening
Remote ECG patient monitoring
Mayo Clinic IP paves way for FDA-cleared remote heart monitoring device
Magnetic Resonance Elastography
Revolutionary imaging tool for diagnosing liver fibrosis
Content displayed is subject to change.